ATEX vs SSP
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, signaling significant operational and profitability concerns. Despite a low P/E of 4.72 and a Graham Number of $38.17 suggesting undervaluation, the negative forward P/E, erratic earnings, and extremely high reported profit margin of 1614% indicate unreliable profitability metrics. The stock trades well below analyst target of $55.33, but weak revenue growth, negative operating margins, and bearish insider activity raise sustainability concerns. Technical trend at 0/100 and declining long-term price performance further support a cautious outlook.
The E.W. Scripps Company exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a high Debt/Equity ratio of 2.19. While the stock trades at a deep discount to book value (P/B 0.53), this is likely a value trap given the structural decline of linear TV and a staggering -23.10% YoY revenue contraction. Recent price momentum appears speculative and disconnected from fundamental performance, as the company has missed earnings estimates in 4 consecutive quarters with an average surprise of -133.96%.
Compare Another Pair
Related Comparisons
ATEX vs SSP: Head-to-Head Comparison
This page compares Anterix Inc. (ATEX) and The E.W. Scripps Company (SSP) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.